Cabaletta Bio (CABA) News Today $1.45 -0.05 (-3.33%) Closing price 04:00 PM EasternExtended Trading$1.48 +0.03 (+2.34%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CABA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Cabaletta Bio to Participate in Upcoming Investor Conferences in SeptemberAugust 27 at 8:00 AM | globenewswire.comFederated Hermes Inc. Raises Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA)August 10, 2025 | marketbeat.comWilliam Blair Sticks to Its Buy Rating for Cabaletta Bio (CABA)August 9, 2025 | theglobeandmail.comCabaletta Bio (NASDAQ:CABA) Given New $2.00 Price Target at Wells Fargo & CompanyAugust 9, 2025 | marketbeat.comCabaletta Bio Advances Rese-cel Pipeline as BLA Submission for Myositis NearsAugust 9, 2025 | msn.comCabaletta Bio files $240M mixed securities shelfAugust 8, 2025 | msn.comCabaletta Bio (CABA) Q2 Loss Widens 30%August 7, 2025 | fool.comCabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 7, 2025 | globenewswire.comCabaletta Bio (CABA) Expected to Release Quarterly Earnings on ThursdayAugust 7, 2025 | marketbeat.comCabaletta Bio, Inc. (NASDAQ:CABA) Given Average Rating of "Buy" by AnalystsAugust 6, 2025 | marketbeat.comIndividual investors who have a significant stake must be disappointed along with institutions after Cabaletta Bio, Inc.'s (NASDAQ:CABA) market cap dropped by US$17mAugust 5, 2025 | finance.yahoo.comCabaletta Bio’s RESET-SLE Study: A Promising Step in Lupus TreatmentJuly 21, 2025 | tipranks.comCabaletta Bio’s RESET-MG Study: A Promising Step in Myasthenia Gravis TreatmentJuly 16, 2025 | tipranks.comCabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of "Buy" from AnalystsJuly 12, 2025 | marketbeat.comCabaletta Bio Inc News (CABA) - Investing.comJuly 11, 2025 | investing.comCabaletta Bio, Inc. (CABA) - Yahoo FinanceJuly 10, 2025 | finance.yahoo.comCabaletta Bio (NASDAQ:CABA) Stock Price Up 1.3% - Still a Buy?July 9, 2025 | marketbeat.comCabaletta Bio, Inc. (NASDAQ:CABA) Receives Average Recommendation of "Buy" from BrokeragesJune 17, 2025 | marketbeat.comMore Data Back CAR T-Cell Therapy for Lupus, With Promise of Wider AvailabilityJune 13, 2025 | msn.comCabaletta Bio Reports Promising Data from RESET Trials for Transformative Autoimmune TherapyJune 12, 2025 | msn.comCabaletta Bio stock tumbles after pricing $100 million public offeringJune 12, 2025 | in.investing.comCabaletta Bio Prices Public Offering to Raise $100 MillionJune 12, 2025 | msn.comCabaletta Bio slides on proposed securities offeringJune 11, 2025 | msn.comCabaletta Shares Tumble After Offering Gets PricedJune 11, 2025 | marketwatch.comCabaletta Bio Announces Public Offering of Common Stock and WarrantsJune 11, 2025 | msn.comCabaletta Bio: Sector Headwinds And Funding Issues... But Also Some Clear Clinical DirectionJune 11, 2025 | seekingalpha.comCabaletta Bio looks to raise $100M in stock sale to fund cell therapy developmentJune 11, 2025 | bizjournals.comCabaletta Bio announces pricing of public offering of securities; shares decline over 28%June 11, 2025 | msn.comCabaletta Bio's (CABA) "Buy" Rating Reiterated at HC WainwrightJune 11, 2025 | marketbeat.comCabaletta Bio Announces Pricing of Public Offering of SecuritiesJune 11, 2025 | globenewswire.comCantor Fitzgerald Predicts Cabaletta Bio FY2026 EarningsJune 11, 2025 | marketbeat.comCabaletta Bio Announces Proposed Public Offering of SecuritiesJune 11, 2025 | globenewswire.comCabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 CongressJune 11, 2025 | globenewswire.comMillennium Management LLC Sells 1,217,300 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA)June 5, 2025 | marketbeat.comTwo Sigma Investments LP Boosts Stock Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA)June 3, 2025 | marketbeat.comTwo Sigma Advisers LP Purchases 550,700 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA)May 31, 2025 | marketbeat.comCabaletta Bio to Participate in the Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comCabaletta Bio, Inc. (NASDAQ:CABA) Given Average Recommendation of "Buy" by AnalystsMay 25, 2025 | marketbeat.comCabaletta Bio (NASDAQ:CABA) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPSMay 23, 2025 | marketbeat.comCantor Fitzgerald Expects Weaker Earnings for Cabaletta BioMay 23, 2025 | marketbeat.comPoint72 Asset Management L.P. Grows Stake in Cabaletta Bio, Inc. (NASDAQ:CABA)May 23, 2025 | marketbeat.com220,000 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Purchased by Raiffeisen Bank International AGMay 20, 2025 | marketbeat.comCabaletta Bio, Inc. (NASDAQ:CABA) Shares Sold by Cubist Systematic Strategies LLCMay 19, 2025 | marketbeat.comCabaletta Bio (CABA) to Release Quarterly Earnings on WednesdayMay 16, 2025 | marketbeat.comCabaletta Bio Stock Surges To 2-Month High On Autoimmune Therapy Progress; Retail’s PleasedMay 15, 2025 | msn.comCabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational CohortsMay 15, 2025 | globenewswire.comFred Alger Management LLC Reduces Stake in Cabaletta Bio, Inc. (NASDAQ:CABA)May 12, 2025 | marketbeat.comCabaletta Bio Inc.May 9, 2025 | marketwatch.com230,161 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Purchased by Renaissance Technologies LLCMay 6, 2025 | marketbeat.comAnalysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $21.00May 3, 2025 | marketbeat.com Get Cabaletta Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for CABA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CABA Media Mentions By Week CABA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CABA News Sentiment▼0.941.04▲Average Medical News Sentiment CABA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CABA Articles This Week▼23▲CABA Articles Average Week Get the Latest News and Ratings for CABA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cabaletta Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies XNCR News Today ANAB News Today PVLA News Today ARVN News Today SAGE News Today ORKA News Today SVRA News Today GOSS News Today RAPP News Today SEPN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CABA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cabaletta Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cabaletta Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access